The companies say they will cooperate fully with the request.
In the meantime, the FDA says the apparent cancer risk is low enough that patients should not stop taking Vytorin or other cholesterol-lowering drugs.
- Get more L.A. breaking news, weather, traffic and sports
- Have a news tip? Send your tips, video, or pictures